Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC...

6
2/2/19 1 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy European Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340 www.escardio.org/guidelines Zwangerschap en hartafwijkingen An Van Berendoncks Belangrijkste oorzaken van moedersterfte Lewis G (ed.). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer—2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl. 1):1–205. MBRRACE-UK 0 5 10 15 20 25 1985-87 1988-90 1991-93 1994-96 1997-99 2000-02 2003-05 cardiac Toename in moedersterfte tgv hartaandoening (deaths/1,000,000 maternities)

Transcript of Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC...

Page 1: Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy European

2/2/19

1

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines

Zwangerschap en hartafwijkingen

An Van Berendoncks

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines

Belangrijkste oorzaken van moedersterfte

Lewis G (ed.). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer—2006–2008. The Eighth Report of the ConfidentialEnquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl. 1):1–205.

MBRRACE-UK

0

5

10

15

20

25

1985-87

1988-90

1991-93

1994-96

1997-99

2000-02

2003-05

cardiac

Toename in moedersterfte tgvhartaandoening(deaths/1,000,000 maternities)

Page 2: Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy European

2/2/19

2

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines

Belangrijkste cardiale oorzaken van moedersterfte

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines

Hoger risico tijdens zwangerschap?

Stijging in linker ventrikel massa en contractiliteit

50-65% stijging CO

20-30% stijging SV

15-30% stijging HF

30% daling SVR

+ 25% arbeid10% contracties

Hoger risico op hartfalen, ritmestoornissen, thrombose

en aorta dissectie tijdens zwangerschap

Page 3: Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy European

2/2/19

3

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines

Risico

2.5-5% 6–10% 10-19% 19-27% 40-100%

% cardiale events moeder

Risico classificatie: mWHO

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines6

Page 4: Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy European

2/2/19

4

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines7

mWHO IGeopereerde eenvoudige letsels

Milde pulmonaalstenose

mWHO II

mWHO II-III

mWHO III

Geopereerde tetralogie van Fallot

Supraventriculaire ritmestoornissen

Hypertrofe cardiomyopathie

Klepijden

Marfan zonder aorta dilatatie

mWHO IV

Mechanische kunstklep

LVEF 30-45%

Complexe congenitale hartziekten

Ernstige aorta dilatatie

LVEF < 30%

Pulmonale hypertensie

Ernstige symptomatische aortaklepstenose

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines8

Page 5: Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy European

2/2/19

5

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines

•Consultatie voor de zwangerschap

Uitleg risico’s en verschillende opties

•Centralisatie van zorg voor alle vrouwen met een

(complexe) hartafwijking

•Behandeling door een multidisciplinair team met

digitaal vastleggen van alle afspraken.

Klinische implicaties

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines

UZA Pregnancy Heart Team

10

An Vorlat Hilde Copejans Yves Jacquemyn

Joke Muys Veronique Van Reeth An Van Berendoncks

Page 6: Presentatie huisartsensymposium zwangerschap 2019 AVB final · 2019. 3. 29. · 2/2/19 2 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy European

2/2/19

6

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyEuropean Heart Journal (2018) 00, 1–83- doi:10.1093/eurheartj/ehy 340

www.escardio.org/guidelines11

Conclusies

Iedere vrouw met cardiale diagnose verdient extra aandacht voor

en tijdens de zwangerschap

Zelfs milde hartdefecten veroorzaken complicaties

Multidisciplinair team met vaste deelnemers